Operational Best Practices To Improve Access in mCRPC

In the final episode ‘Operational Best Practices To Improve Access in mCRPC,’ the expert prior authorization specialist explored the following critical questions:
1. What best practices have you found for timing prior authorization submissions to avoid delays or gaps in access, particularly around weekends or non-business days?

2. How can delays in prior authorization approval affect treatment timelines, disease progression risk, or therapeutic sequencing in mCRPC?

1. How frequently do you experience delays in prior authorization, and how do you manage them in practice?

3.How does the route of administration (oral, injectable, or infused) impact prior authorization processes and access to therapies in mCRPC?

4. How often do you utilize buy-and-bill in your practice and for which therapies in mCRPC?

5. How is your practice structured to facilitate prior authorization and patient access to therapies in mCRPC?

6. What guidance would you offer to clinicians regarding documentation at the time of patient visits to streamline prior authorization and avoid delays in mCRPC?

7. What final advice would you like to share with office staff that is submitting prior authorization and access to novel therapies?

The moderator discussed practical workflow strategies to support timely access to therapies in metastatic castration-resistant prostate cancer (mCRPC). Faculty will discuss best practices for timing prior authorization submissions and ensuring rapid response to payer requests to minimize delays. The impact of prior authorization timing and documentation accuracy on treatment timelines and disease progression will be explored. Operational approaches, including the use of in-house pharmacy services and buy-and-bill models, will be reviewed as mechanisms to streamline access. The discussion will conclude with recommendations for standardized documentation and a patient-centered approach to ensure efficient and compassionate care delivery.

Thank you for watching this Urology Times Insights series on prior authorization processes in mCRPC. Please subscribe to our newsletter for information on upcoming video series.